Anebulo Pharmaceuticals (ANEB) Other Non-Current Assets (2021 - 2025)
Anebulo Pharmaceuticals' Other Non-Current Assets was $148,231 in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 66.7% from $445,731 a year earlier and down 25.9% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Other Non-Current Assets (2021 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Other Non-Current Assets at Anebulo Pharmaceuticals came in at $200,000, down 66.7% from FY2024.
- In earlier fiscal years, Other Non-Current Assets was $600,000 in FY2024.
- The fiscal Q2 2026 figure marks the lowest quarterly Other Non-Current Assets in data going back to fiscal Q3 2021.
- Compared with a year earlier, Other Non-Current Assets has declined for five straight quarters, with an average decline of 59.6% over the last five quarters.
- Per Business Quant data, ANEB's Other Non-Current Assets in the three fiscal quarters before Q2 2026 was $200,000 (Q1 2026), $200,000 (Q4 2025) and $200,549 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | 148,231.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 148,231.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,549.00 |
| Dec 31, 2024 | 445,731.00 |
| Sep 30, 2024 | 505,427.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 624,820.00 |
| Dec 31, 2023 | 700,000.00 |
| Mar 31, 2021 | 392,730.00 |
API Access
Anebulo Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();